Logo image of SPAI

SAFE PRO GROUP INC (SPAI) Stock Fundamental Analysis

NASDAQ:SPAI - Nasdaq - US78642D1019 - Common Stock - Currency: USD

4.14  +0.59 (+16.62%)

After market: 4.0987 -0.04 (-1%)

Fundamental Rating

2

Overall SPAI gets a fundamental rating of 2 out of 10. We evaluated SPAI against 67 industry peers in the Aerospace & Defense industry. While SPAI seems to be doing ok healthwise, there are quite some concerns on its profitability. SPAI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year SPAI has reported negative net income.
SPAI had a negative operating cash flow in the past year.
SPAI Yearly Net Income VS EBIT VS OCF VS FCFSPAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

With a Return On Assets value of -278.02%, SPAI is not doing good in the industry: 92.54% of the companies in the same industry are doing better.
SPAI has a Return On Equity of -387.74%. This is amonst the worse of the industry: SPAI underperforms 85.07% of its industry peers.
Industry RankSector Rank
ROA -278.02%
ROE -387.74%
ROIC N/A
ROA(3y)-115.38%
ROA(5y)N/A
ROE(3y)-188.96%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SPAI Yearly ROA, ROE, ROICSPAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -100 -200 -300

1.3 Margins

The Gross Margin of SPAI (41.26%) is better than 83.58% of its industry peers.
SPAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SPAI Yearly Profit, Operating, Gross MarginsSPAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -200 -400 -600

4

2. Health

2.1 Basic Checks

SPAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SPAI has been increased compared to 1 year ago.
Compared to 1 year ago, SPAI has an improved debt to assets ratio.
SPAI Yearly Shares OutstandingSPAI Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M
SPAI Yearly Total Debt VS Total AssetsSPAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1M 2M 3M 4M

2.2 Solvency

SPAI has an Altman-Z score of 15.79. This indicates that SPAI is financially healthy and has little risk of bankruptcy at the moment.
SPAI has a better Altman-Z score (15.79) than 94.03% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that SPAI is not too dependend on debt financing.
SPAI has a Debt to Equity ratio of 0.06. This is amongst the best in the industry. SPAI outperforms 85.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 15.79
ROIC/WACCN/A
WACC10.32%
SPAI Yearly LT Debt VS Equity VS FCFSPAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2M -2M -4M

2.3 Liquidity

SPAI has a Current Ratio of 1.70. This is a normal value and indicates that SPAI is financially healthy and should not expect problems in meeting its short term obligations.
SPAI has a Current ratio of 1.70. This is in the lower half of the industry: SPAI underperforms 61.19% of its industry peers.
SPAI has a Quick Ratio of 1.34. This is a normal value and indicates that SPAI is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.34, SPAI perfoms like the industry average, outperforming 46.27% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.34
SPAI Yearly Current Assets VS Current LiabilitesSPAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M 2M 2.5M

1

3. Growth

3.1 Past

SPAI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -53.62%.
The Revenue has grown by 136.37% in the past year. This is a very strong growth!
EPS 1Y (TTM)-53.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-225.94%
Revenue 1Y (TTM)136.37%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-39.94%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SPAI Yearly Revenue VS EstimatesSPAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 500K 1M 1.5M 2M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SPAI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SPAI Price Earnings VS Forward Price EarningsSPAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SPAI Per share dataSPAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SPAI!.
Industry RankSector Rank
Dividend Yield N/A

SAFE PRO GROUP INC

NASDAQ:SPAI (8/8/2025, 8:07:15 PM)

After market: 4.0987 -0.04 (-1%)

4.14

+0.59 (+16.62%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.24%
Inst Owner Change0%
Ins Owners51.36%
Ins Owner Change6.38%
Market Cap62.80M
AnalystsN/A
Price TargetN/A
Short Float %0.3%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 30.69
P/FCF N/A
P/OCF N/A
P/B 23.76
P/tB 73.97
EV/EBITDA N/A
EPS(TTM)-0.8
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS0.13
BVpS0.17
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -278.02%
ROE -387.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.26%
FCFM N/A
ROA(3y)-115.38%
ROA(5y)N/A
ROE(3y)-188.96%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.7
Quick Ratio 1.34
Altman-Z 15.79
F-Score5
WACC10.32%
ROIC/WACCN/A
Cap/Depr(3y)55.18%
Cap/Depr(5y)N/A
Cap/Sales(3y)8.56%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-225.94%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)136.37%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-39.94%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-122.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-104.37%
OCF growth 3YN/A
OCF growth 5YN/A